Cargando…

rowth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus

Neurodegeneration is an initial process in the development of diabetic retinopathy (DR). High quantities of glutamate, oxidative stress, induction of the renin-angiotensin system (RAS) and elevated levels of RAGE are crucial elements in the retinal neurodegeneration caused by diabetes mellitus. At l...

Descripción completa

Detalles Bibliográficos
Autor principal: Iwona, Ben-Skowronek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333593/
https://www.ncbi.nlm.nih.gov/pubmed/27528260
http://dx.doi.org/10.2174/1570159X14666160813182009
_version_ 1782511739335606272
author Iwona, Ben-Skowronek
author_facet Iwona, Ben-Skowronek
author_sort Iwona, Ben-Skowronek
collection PubMed
description Neurodegeneration is an initial process in the development of diabetic retinopathy (DR). High quantities of glutamate, oxidative stress, induction of the renin-angiotensin system (RAS) and elevated levels of RAGE are crucial elements in the retinal neurodegeneration caused by diabetes mellitus. At least, there is emerging proof to indicate that the equilibrium between the neurotoxic and neuroprotective components will affect the state of the retinal neurons. Somatostatin (SST), pigment epithelium-derived factor (PEDF), and erythropoietin (Epo) are endogenous neuroprotective peptides that are decreased in the eye of diabetic persons and play an essential role in retinal homeostasis. On the other hand, insulin-like growth factor 1 (IGF-1), and vascular endothelial growth factor (VEGF) are pivotal proteins which participate in the development of new capillaries and finally cause damage to the retinal neurons. During recent years, our knowledge about the function of growth factors in the pathogenesis of retinal neurodegeneration has increased. However, intensive investigations are needed to clarify the basic processes that contribute to retinal neurodegeneration and its association with damage to the capillary blood vessels. The objective of this review article is to show new insights on the role of neurotransmitters and growth factors in the pathogenesis of diabetic retinopathy. The information contained in this manuscript may provide the basis for novel strategies based on the factors of neurodegeneration to diagnose, prevent and treat DR in its earliest phases.
format Online
Article
Text
id pubmed-5333593
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-53335932017-05-01 rowth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus Iwona, Ben-Skowronek Curr Neuropharmacol Article Neurodegeneration is an initial process in the development of diabetic retinopathy (DR). High quantities of glutamate, oxidative stress, induction of the renin-angiotensin system (RAS) and elevated levels of RAGE are crucial elements in the retinal neurodegeneration caused by diabetes mellitus. At least, there is emerging proof to indicate that the equilibrium between the neurotoxic and neuroprotective components will affect the state of the retinal neurons. Somatostatin (SST), pigment epithelium-derived factor (PEDF), and erythropoietin (Epo) are endogenous neuroprotective peptides that are decreased in the eye of diabetic persons and play an essential role in retinal homeostasis. On the other hand, insulin-like growth factor 1 (IGF-1), and vascular endothelial growth factor (VEGF) are pivotal proteins which participate in the development of new capillaries and finally cause damage to the retinal neurons. During recent years, our knowledge about the function of growth factors in the pathogenesis of retinal neurodegeneration has increased. However, intensive investigations are needed to clarify the basic processes that contribute to retinal neurodegeneration and its association with damage to the capillary blood vessels. The objective of this review article is to show new insights on the role of neurotransmitters and growth factors in the pathogenesis of diabetic retinopathy. The information contained in this manuscript may provide the basis for novel strategies based on the factors of neurodegeneration to diagnose, prevent and treat DR in its earliest phases. Bentham Science Publishers 2016-11 2016-11 /pmc/articles/PMC5333593/ /pubmed/27528260 http://dx.doi.org/10.2174/1570159X14666160813182009 Text en © 2016 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Iwona, Ben-Skowronek
rowth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus
title rowth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus
title_full rowth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus
title_fullStr rowth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus
title_full_unstemmed rowth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus
title_short rowth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus
title_sort rowth factors in the pathogenesis of retinal neurodegeneration in diabetes mellitus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333593/
https://www.ncbi.nlm.nih.gov/pubmed/27528260
http://dx.doi.org/10.2174/1570159X14666160813182009
work_keys_str_mv AT iwonabenskowronek rowthfactorsinthepathogenesisofretinalneurodegenerationindiabetesmellitus